Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer.
Alexandra N CorellaMa Victoria Andrea Cabiliza OrdonioIlsa ColemanJared M LucasArja KaipainenHolly M NguyenDaniel SondheimLisha G BrownLawrence D TrueJohn K LeeDavid MacPhersonPaul T NghiemRoman GulatiColm MorrisseyEva CoreyPeter S NelsonPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
The combination of BCL2 and Wee1 inhibition presents a novel therapeutic strategy for the treatment of SCNPC.